(RTTNews) - Eagle Pharmaceuticals, Inc. (EGRX) and Enalare Therapeutics Inc. announced Monday that the U.S. Food and Drug Administration has granted Orphan Drug Designation to ENA-001 for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results